Stay updated on OPTIMISE Clinical Trial: Secukinumab in Psoriasis
Sign up to get notified when there's something new on the OPTIMISE Clinical Trial: Secukinumab in Psoriasis page.

Latest updates to the OPTIMISE Clinical Trial: Secukinumab in Psoriasis page
- Check5 days agoChange DetectedA new revision label v3.5.5 was added to the page's revision history, and the previous label v3.5.4 was removed. This indicates the page content has been updated to a newer version.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a minor update to the page’s revision history. The change does not modify content or user-facing features.SummaryDifference0.0%

- Check33 days agoChange DetectedUpdated the study location entry to Malmö, Sweden, SE-205 02. The previous listing Malmo, Sweden, SE-205 02 was replaced to reflect the correct spelling.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page revision label was updated from v3.5.2 to v3.5.3, indicating a refreshed version of the content with minor edits to the study record.SummaryDifference0.0%

- Check55 days agoChange DetectedRevisions were updated to replace v3.5.0 with v3.5.2.SummaryDifference0.0%

- Check83 days agoChange DetectedRevision 3.5.0 was added to the revision history, and Revision 3.4.3 was removed.SummaryDifference0.0%

Stay in the know with updates to OPTIMISE Clinical Trial: Secukinumab in Psoriasis
Enter your email address, and we'll notify you when there's something new on the OPTIMISE Clinical Trial: Secukinumab in Psoriasis page.